Product Code: SR112023A2202
Abstract
Market Overview:
The global embolic protection devices market size reached US$ 1,069 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 1,706 Million by 2028, exhibiting a growth rate (CAGR) of 8.3% during 2023-2028.
Embolic protection devices (EPD) trap blood and luminal debris within the saphenous vein graft (SVG) during stenting to prevent distal embolization. There are three classes of these devices, including distal occlusion devices, distal filters and proximal occlusion devices. These devices provide the most verified strategy to reduce periprocedural myocardial infarction (MI) and major adverse cardiovascular events by capturing and removing debris that may get dislodged during surgical procedures such as SVG interventions, percutaneous coronary intervention, aortic valve stenosis, etc.
The increasing prevalence of cardiovascular diseases (CVDs) represent one of the key factors driving the market growth. EPDs are crucial in reducing complications arising due to blockages in small blood vessels caused by the debris that is released into the bloodstream. They form a part of the most reliable, evidence-based procedure for reducing periprocedural MI and other major cardiovascular events. This, coupled with increasing instances of cardiac arrests and other heart-related issues, is providing a significant boost to the market for EPDs. Furthermore, governments of several nations across the globe are investing in increasing their research and development (R&D) capabilities, which is acting as another major growth-inducing factor. Steadily increasing geriatric population across the world, which is more susceptible to chronic medical illnesses, is also contributing to the market growth. The rising demand for minimally invasive products and several technological advancements, along with the significant growth in the healthcare sector, are some of the other factors that are expected to further create a positive outlook for the market.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global embolic protection devices market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product, application, procedure, material, usage and end-user.
Breakup by Product:
Distal Filter Devices
Distal Occlusion Devices
Proximal Occlusion Devices
Breakup by Application:
Coronary Artery Treatment
Carotid Artery Treatment
Others
Breakup by Procedure:
Percutaneous Coronary Intervention
Carotid Artery Stenosis
Saphenous Vein Graft Intervention
Aortic Valve Stenosis (Transcatheter Aortic Valve Replacement)
Others
Breakup by Material:
Nitinol
Polyurethane
Breakup by Usage:
Disposable Devices
Re-Usable Devices
Breakup by End-User:
Hospitals and Clinics
Ambulatory Surgical Centers
Others
Breakup by Region:
North America
United States
Canada
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined with some of the key players being Abbott Laboratories, Allium Medical Solutions Ltd., Boston Scientific Corporation, Cardinal Health Inc., Contego Medical LLC, Innovative Cardiovascular Solutions LLC, Edwards Lifesciences Corporation, Medtronic Inc., Silk Road Medical Inc., etc.
Key Questions Answered in This Report
- 1. What was the size of the global embolic protection devices market in 2022?
- 2. What is the expected growth rate of the global embolic protection devices market during 2023-2028?
- 3. What has been the impact of COVID-19 on the global embolic protection devices market?
- 4. What are the key factors driving the global embolic protection devices market?
- 5. What is the breakup of the global embolic protection devices market based on the product?
- 6. What is the breakup of the global embolic protection devices market based on the application?
- 7. What is the breakup of the global embolic protection devices market based on the procedure?
- 8. What is the breakup of the global embolic protection devices market based on the material?
- 9. What is the breakup of the global embolic protection devices market based on the usage?
- 10. What is the breakup of the global embolic protection devices market based on the end-user?
- 11. What are the key regions in the global embolic protection devices market?
- 12. Who are the key players/companies in the global embolic protection devices market?
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global Embolic Protection Devices Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
6 Market Breakup by Product
- 6.1 Distal Filter Devices
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
- 6.2 Distal Occlusion Devices
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
- 6.3 Proximal Occlusion Devices
- 6.3.1 Market Trends
- 6.3.2 Market Forecast
7 Market Breakup by Application
- 7.1 Coronary Artery Treatment
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 Carotid Artery Treatment
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
- 7.3 Others
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
8 Market Breakup by Procedure
- 8.1 Percutaneous Coronary Intervention
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
- 8.2 Carotid Artery Stenosis
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
- 8.3 Saphenous Vein Graft Intervention
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
- 8.4 Aortic Valve Stenosis (Transcatheter Aortic Valve Replacement)
- 8.4.1 Market Trends
- 8.4.2 Market Forecast
- 8.5 Others
- 8.5.1 Market Trends
- 8.5.2 Market Forecast
9 Market Breakup by Material
- 9.1 Nitinol
- 9.1.1 Market Trends
- 9.1.2 Market Forecast
- 9.2 Polyurethane
- 9.2.1 Market Trends
- 9.2.2 Market Forecast
10 Market Breakup by Usage
- 10.1 Disposable Devices
- 10.1.1 Market Trends
- 10.1.2 Market Forecast
- 10.2 Re-Usable Devices
- 10.2.1 Market Trends
- 10.2.2 Market Forecast
11 Market Breakup by End-User
- 11.1 Hospitals and Clinics
- 11.1.1 Market Trends
- 11.1.2 Market Forecast
- 11.2 Ambulatory Surgical Centers
- 11.2.1 Market Trends
- 11.2.2 Market Forecast
- 11.3 Others
- 11.3.1 Market Trends
- 11.3.2 Market Forecast
12 Market Breakup by Region
- 12.1 North America
- 12.1.1 United States
- 12.1.1.1 Market Trends
- 12.1.1.2 Market Forecast
- 12.1.2 Canada
- 12.1.2.1 Market Trends
- 12.1.2.2 Market Forecast
- 12.2 Asia Pacific
- 12.2.1 China
- 12.2.1.1 Market Trends
- 12.2.1.2 Market Forecast
- 12.2.2 Japan
- 12.2.2.1 Market Trends
- 12.2.2.2 Market Forecast
- 12.2.3 India
- 12.2.3.1 Market Trends
- 12.2.3.2 Market Forecast
- 12.2.4 South Korea
- 12.2.4.1 Market Trends
- 12.2.4.2 Market Forecast
- 12.2.5 Australia
- 12.2.5.1 Market Trends
- 12.2.5.2 Market Forecast
- 12.2.6 Indonesia
- 12.2.6.1 Market Trends
- 12.2.6.2 Market Forecast
- 12.2.7 Others
- 12.2.7.1 Market Trends
- 12.2.7.2 Market Forecast
- 12.3 Europe
- 12.3.1 Germany
- 12.3.1.1 Market Trends
- 12.3.1.2 Market Forecast
- 12.3.2 France
- 12.3.2.1 Market Trends
- 12.3.2.2 Market Forecast
- 12.3.3 United Kingdom
- 12.3.3.1 Market Trends
- 12.3.3.2 Market Forecast
- 12.3.4 Italy
- 12.3.4.1 Market Trends
- 12.3.4.2 Market Forecast
- 12.3.5 Spain
- 12.3.5.1 Market Trends
- 12.3.5.2 Market Forecast
- 12.3.6 Russia
- 12.3.6.1 Market Trends
- 12.3.6.2 Market Forecast
- 12.3.7 Others
- 12.3.7.1 Market Trends
- 12.3.7.2 Market Forecast
- 12.4 Latin America
- 12.4.1 Brazil
- 12.4.1.1 Market Trends
- 12.4.1.2 Market Forecast
- 12.4.2 Mexico
- 12.4.2.1 Market Trends
- 12.4.2.2 Market Forecast
- 12.4.3 Others
- 12.4.3.1 Market Trends
- 12.4.3.2 Market Forecast
- 12.5 Middle East and Africa
- 12.5.1 Market Trends
- 12.5.2 Market Breakup by Country
- 12.5.3 Market Forecast
13 SWOT Analysis
- 13.1 Overview
- 13.2 Strengths
- 13.3 Weaknesses
- 13.4 Opportunities
- 13.5 Threats
14 Value Chain Analysis
15 Porters Five Forces Analysis
- 15.1 Overview
- 15.2 Bargaining Power of Buyers
- 15.3 Bargaining Power of Suppliers
- 15.4 Degree of Competition
- 15.5 Threat of New Entrants
- 15.6 Threat of Substitutes
16 Price Indicators
17 Competitive Landscape
- 17.1 Market Structure
- 17.2 Key Players
- 17.3 Profiles of Key Players
- 17.3.1 Abbott Laboratories
- 17.3.1.1 Company Overview
- 17.3.1.2 Product Portfolio
- 17.3.1.3 Financials
- 17.3.1.4 SWOT Analysis
- 17.3.2 Allium Medical Solutions Ltd.
- 17.3.2.1 Company Overview
- 17.3.2.2 Product Portfolio
- 17.3.2.3 Financials
- 17.3.3 Boston Scientific Corporation
- 17.3.3.1 Company Overview
- 17.3.3.2 Product Portfolio
- 17.3.3.3 Financials
- 17.3.3.4 SWOT Analysis
- 17.3.4 Cardinal Health Inc.
- 17.3.4.1 Company Overview
- 17.3.4.2 Product Portfolio
- 17.3.4.3 Financials
- 17.3.4.4 SWOT Analysis
- 17.3.5 Contego Medical LLC
- 17.3.5.1 Company Overview
- 17.3.5.2 Product Portfolio
- 17.3.6 Innovative Cardiovascular Solutions LLC
- 17.3.6.1 Company Overview
- 17.3.6.2 Product Portfolio
- 17.3.7 Edwards Lifesciences Corporation
- 17.3.7.1 Company Overview
- 17.3.7.2 Product Portfolio
- 17.3.7.3 Financials
- 17.3.7.4 SWOT Analysis
- 17.3.8 Medtronic Inc.
- 17.3.8.1 Company Overview
- 17.3.8.2 Product Portfolio
- 17.3.8.3 Financials
- 17.3.8.4 SWOT Analysis
- 17.3.9 Silk Road Medical Inc.
- 17.3.9.1 Company Overview
- 17.3.9.2 Product Portfolio
- 17.3.9.3 Financials